386 related articles for article (PubMed ID: 20656837)
1. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
[TBL] [Abstract][Full Text] [Related]
2. Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable?
Ringe KI; Gupta RT; Brady CM; Massey CM; Hahn A; Galanski M; Merkle EM; Lotz J
Radiology; 2010 May; 255(2):451-8. PubMed ID: 20413758
[TBL] [Abstract][Full Text] [Related]
3. Thick-section half-Fourier rapid acquisition with relaxation enhancement MR cholangiopancreatography: effects of i.v. administration of gadolinium chelate.
Kanematsu M; Matsuo M; Shiratori Y; Kondo H; Hoshi H; Yasuda I; Moriwaki H
AJR Am J Roentgenol; 2002 Mar; 178(3):755-61. PubMed ID: 11856714
[TBL] [Abstract][Full Text] [Related]
4. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
[TBL] [Abstract][Full Text] [Related]
5. MR cholangiopancreatography at 3.0 T: intraindividual comparative study with MR cholangiopancreatography at 1.5 T for clinical patients.
Onishi H; Kim T; Hori M; Murakami T; Tatsumi M; Nakaya Y; Nakamoto A; Osuga K; Tomoda K; Nakamura H
Invest Radiol; 2009 Sep; 44(9):559-65. PubMed ID: 19692840
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
[TBL] [Abstract][Full Text] [Related]
7. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
Park MJ; Kim YK; Lim S; Rhim H; Lee WJ
Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
[TBL] [Abstract][Full Text] [Related]
9. Detection of active bile leak with Gd-EOB-DTPA enhanced MR cholangiography: comparison of 20-25 min delayed and 60-180 min delayed images.
Cieszanowski A; Stadnik A; Lezak A; Maj E; Zieniewicz K; Rowinska-Berman K; Grudzinski IP; Krawczyk M; Rowiński O
Eur J Radiol; 2013 Dec; 82(12):2176-82. PubMed ID: 24012454
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques.
Sodickson A; Mortele KJ; Barish MA; Zou KH; Thibodeau S; Tempany CM
Radiology; 2006 Feb; 238(2):549-59. PubMed ID: 16436816
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of acetabular labral tears: comparison of three-dimensional intermediate-weighted fast spin-echo MR arthrography with two-dimensional MR arthrography at 3.0 T.
Park SY; Park JS; Jin W; Rhyu KH; Ryu KN
Acta Radiol; 2013 Feb; 54(1):75-82. PubMed ID: 23093725
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid.
Kim YK; Kwak HS; Kim CS; Han YM
J Magn Reson Imaging; 2009 Aug; 30(2):437-43. PubMed ID: 19629973
[TBL] [Abstract][Full Text] [Related]
13. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
Ahn SS; Kim MJ; Lim JS; Hong HS; Chung YE; Choi JY
Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
[TBL] [Abstract][Full Text] [Related]
14. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
16. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
17. Isotropic 3D T2-weighted MR cholangiopancreatography with parallel imaging: feasibility study.
Zhang J; Israel GM; Hecht EM; Krinsky GA; Babb JS; Lee VS
AJR Am J Roentgenol; 2006 Dec; 187(6):1564-70. PubMed ID: 17114551
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing hemangiomas from malignant solid hepatic lesions: a comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid.
Ahn SJ; Kim MJ; Hong HS; Kim KA; Song HT
J Magn Reson Imaging; 2011 Aug; 34(2):310-7. PubMed ID: 21598345
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
